{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T23:25:16Z","timestamp":1794266716913,"version":"4.9.0"},"reference-count":28,"publisher":"American Medical Association (AMA)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Oncol"],"published-print":{"date-parts":[[2021,8,1]]},"DOI":"10.1001\/jamaoncol.2021.1590","type":"journal-article","created":{"date-parts":[[2021,6,3]],"date-time":"2021-06-03T18:18:19Z","timestamp":1622744299000},"page":"1203","source":"Crossref","is-referenced-by-count":89,"title":["Association of Salpingectomy With Delayed Oophorectomy Versus Salpingo-oophorectomy With Quality of Life in <i>BRCA1\/2<\/i> Pathogenic Variant Carriers"],"prefix":"10.1001","volume":"7","author":[{"given":"Miranda P.","family":"Steenbeek","sequence":"first","affiliation":[{"name":"Radboud Institute for Health Sciences, Department of Obstetrics and Gynaecology, Radboud University Medical Center, Nijmegen, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marline G.","family":"Harmsen","sequence":"additional","affiliation":[{"name":"Radboud Institute for Health Sciences, Department of Obstetrics and Gynaecology, Radboud University Medical Center, Nijmegen, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicoline","family":"Hoogerbrugge","sequence":"additional","affiliation":[{"name":"Department of Human Genetics, Radboud University Medical Center, Nijmegen, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marieke Arts","family":"de Jong","sequence":"additional","affiliation":[{"name":"Radboud Institute for Health Sciences, Department of Obstetrics and Gynaecology, Radboud University Medical Center, Nijmegen, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela H. E. M.","family":"Maas","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Radboud University Medical Center, Nijmegen, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith B.","family":"Prins","sequence":"additional","affiliation":[{"name":"Department of Medical Psychology, Radboud University Medical Center, Nijmegen, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Bulten","sequence":"additional","affiliation":[{"name":"Department of Pathology, Radboud University Medical Center, Nijmegen, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Teerenstra","sequence":"additional","affiliation":[{"name":"Department for Health Evidence, Radboud University Medical Center, Nijmegen, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Majke H. D.","family":"van Bommel","sequence":"additional","affiliation":[{"name":"Radboud Institute for Health Sciences, Department of Obstetrics and Gynaecology, Radboud University Medical Center, Nijmegen, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena C.","family":"van Doorn","sequence":"additional","affiliation":[{"name":"Department of Gynecology, Erasmus MC Cancer Clinic, Rotterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marian J. E.","family":"Mourits","sequence":"additional","affiliation":[{"name":"Department of Gynecologic Oncology, University of Groningen, University Medical Centre Groningen, Groningen, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"van Beurden","sequence":"additional","affiliation":[{"name":"Centre for Gynecological Oncology Amsterdam, Netherlands Cancer Institute\/Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald P.","family":"Zweemer","sequence":"additional","affiliation":[{"name":"Department of Gynecological Oncology, UMC Utrecht Cancer Centre, Utrecht, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katja N.","family":"Gaarenstroom","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Leiden University Medical Centre, Leiden, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigitte F. M.","family":"Slangen","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Maastricht University Medical Centre, GROW-School for Oncology and Developmental Biology, Maastricht, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monique M. A.","family":"Brood-van Zanten","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Netherlands Cancer Institute\/Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands"},{"name":"Department of Obstetrics and Gynecology, AmsterdamUMC, Amsterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Caroline","family":"Vos","sequence":"additional","affiliation":[{"name":"Gynecologic Oncologic Centre South location Elisabeth-TweeSteden Hospital, Tilburg, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jurgen M. J.","family":"Piek","sequence":"additional","affiliation":[{"name":"Gynecologic Oncologic Centre South location Catharina Hospital, Eindhoven, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc R. C. W.","family":"van Lonkhuijzen","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, AmsterdamUMC, Amsterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirjam J. A.","family":"Apperloo","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Medical Centre Leeuwarden, Leeuwarden, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sjors F. P. J.","family":"Coppus","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Maxima Medical Centre, Veldhoven, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leon F. A. G.","family":"Massuger","sequence":"additional","affiliation":[{"name":"Radboud Institute for Health Sciences, Department for Health Evidence, Radboud University Medical Center, Nijmegen, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"IntHout","sequence":"additional","affiliation":[{"name":"Scientific Institute for Quality of Healthcare, Radboud University Medical Center, Nijmegen, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosella P. M. G.","family":"Hermens","sequence":"additional","affiliation":[{"name":"Scientific Institute for Quality of Healthcare, Radboud University Medical Center, Nijmegen, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne A.","family":"de Hullu","sequence":"additional","affiliation":[{"name":"Radboud Institute for Health Sciences, Department of Obstetrics and Gynaecology, Radboud University Medical Center, Nijmegen, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"23","key":"coi210020r1","doi-asserted-by":"publisher","first-page":"2402","DOI":"10.1001\/jama.2017.7112","article-title":"Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers.","volume":"317","author":"Kuchenbaecker","year":"2017","journal-title":"JAMA"},{"issue":"6","key":"coi210020r2","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1038\/sj.bjc.6603015","article-title":"Surveillance of women at high risk for hereditary ovarian cancer is inefficient.","volume":"94","author":"Oei","year":"2006","journal-title":"Br J Cancer"},{"issue":"9","key":"coi210020r4","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1001\/jama.2010.1237","article-title":"Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality.","volume":"304","author":"Domchek","year":"2010","journal-title":"JAMA"},{"issue":"3","key":"coi210020r5","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1080\/13697137.2017.1285879","article-title":"Impact of risk-reducing salpingo-oophorectomy in premenopausal women.","volume":"20","author":"Vermeulen","year":"2017","journal-title":"Climacteric"},{"issue":"11","key":"coi210020r6","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1016\/j.mayocp.2016.08.002","article-title":"Accelerated accumulation of multimorbidity after bilateral oophorectomy: a population-based cohort study.","volume":"91","author":"Rocca","year":"2016","journal-title":"Mayo Clin Proc"},{"issue":"4","key":"coi210020r7","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1002\/(ISSN)1096-9896","article-title":"Dysplastic changes in prophylactically removed Fallopian tubes of women predisposed to developing ovarian cancer.","volume":"195","author":"Piek","year":"2001","journal-title":"J Pathol"},{"issue":"1","key":"coi210020r8","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1038\/s41467-017-00962-1","article-title":"High grade serous ovarian carcinomas originate in the fallopian tube.","volume":"8","author":"Labidi-Galy","year":"2017","journal-title":"Nat Commun"},{"issue":"2","key":"coi210020r9","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.ygyno.2014.12.031","article-title":"Risk-reducing salpingectomy with delayed oophorectomy in BRCA1\/2 mutation carriers: patients\u2019 and professionals\u2019 perspectives.","volume":"136","author":"Arts-de Jong","year":"2015","journal-title":"Gynecol Oncol"},{"issue":"2","key":"coi210020r10","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.ygyno.2014.02.030","article-title":"Acceptability of prophylactic salpingectomy with delayed oophorectomy as risk-reducing surgery among BRCA mutation carriers.","volume":"133","author":"Holman","year":"2014","journal-title":"Gynecol Oncol"},{"key":"coi210020r11","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1186\/s12885-015-1597-y","article-title":"Early salpingectomy (tubectomy) with delayed oophorectomy to improve quality of life as alternative for risk-reducing salpingo-oophorectomy in BRCA1\/2 mutation carriers (TUBA study): a prospective non-randomised multicentre study.","volume":"15","author":"Harmsen","year":"2015","journal-title":"BMC Cancer"},{"issue":"2","key":"coi210020r12","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1097\/01.pas.0000180854.28831.77","article-title":"The tubal fimbria is a preferred site for early adenocarcinoma in women with familial ovarian cancer syndrome.","volume":"30","author":"Medeiros","year":"2006","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"coi210020r13","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.ygyno.2016.07.104","article-title":"Very high uptake of risk-reducing salpingo-oophorectomy in BRCA1\/2 mutation carriers: a single-center experience.","volume":"143","author":"Harmsen","year":"2016","journal-title":"Gynecol Oncol"},{"issue":"3","key":"coi210020r14","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1111\/hex.2018.21.issue-3","article-title":"A patient decision aid for risk-reducing surgery in premenopausal BRCA1\/2 mutation carriers: Development process and pilot testing.","volume":"21","author":"Harmsen","year":"2018","journal-title":"Health Expect"},{"issue":"2","key":"coi210020r15","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/S0378-5122(00)00212-7","article-title":"Climacteric symptoms in a representative Dutch population sample as measured with the Greene Climacteric Scale.","volume":"38","author":"Barentsen","year":"2001","journal-title":"Maturitas"},{"issue":"4","key":"coi210020r16","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1080\/00926230600666261","article-title":"The Female Sexual Function Index (FSFI) and the Female Sexual Distress Scale (FSDS): psychometric properties within a Dutch population.","volume":"32","author":"ter Kuile","year":"2006","journal-title":"J Sex Marital Ther"},{"issue":"6","key":"coi210020r18","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","article-title":"The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection.","volume":"30","author":"Ware","year":"1992","journal-title":"Med Care"},{"issue":"6","key":"coi210020r19","doi-asserted-by":"publisher","first-page":"666","DOI":"10.3109\/13697137.2014.913284","article-title":"Symptoms, health behavior and understanding of menopause therapy in women with premature menopause.","volume":"17","author":"Gibson-Helm","year":"2014","journal-title":"Climacteric"},{"issue":"1","key":"coi210020r20","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.ygyno.2018.04.564","article-title":"Bilateral salpingectomy with delayed oophorectomy for ovarian cancer risk reduction: a pilot study in women with BRCA1\/2 mutations.","volume":"150","author":"Nebgen","year":"2018","journal-title":"Gynecol Oncol"},{"issue":"22","key":"coi210020r21","doi-asserted-by":"publisher","first-page":"3576","DOI":"10.1200\/JCO.2005.05.1896","article-title":"The impact of hormone replacement therapy on menopausal symptoms in younger high-risk women after prophylactic salpingo-oophorectomy.","volume":"24","author":"Madalinska","year":"2006","journal-title":"J Clin Oncol"},{"issue":"12","key":"coi210020r22","doi-asserted-by":"publisher","first-page":"1766","DOI":"10.1097\/PAS.0b013e31822f58bc","article-title":"Diagnosis of serous tubal intraepithelial carcinoma based on morphologic and immunohistochemical features: a reproducibility study.","volume":"35","author":"Visvanathan","year":"2011","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"coi210020r23","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djv033","article-title":"Breast cancer risk after salpingo-oophorectomy in healthy BRCA1\/2 mutation carriers: revisiting the evidence for risk reduction.","volume":"107","author":"Heemskerk-Gerritsen","year":"2015","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"coi210020r24","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s13058-020-1247-4","article-title":"Risk-reducing salpingo-oophorectomy, natural menopause, and breast cancer risk: an international prospective cohort of BRCA1 and BRCA2 mutation carriers.","volume":"22","author":"Mavaddat","year":"2020","journal-title":"Breast Cancer Res"},{"issue":"1","key":"coi210020r25","article-title":"Risk-reducing salpingo-oophorectomy and breast cancer risk reduction in the Gynecologic Oncology Group Protocol-0199 (GOG-0199).","volume":"4","author":"Mai","year":"2019","journal-title":"J Natl Cancer Inst Cancer Spectr"},{"issue":"11","key":"coi210020r26","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1158\/1940-6207.CAPR-12-0190","article-title":"Breast cancer incidence after risk-reducing salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers.","volume":"5","author":"Fakkert","year":"2012","journal-title":"Cancer Prev Res (Phila)"},{"key":"coi210020r3","unstructured":"Integraal Kankercentrum Nederland. Richtlijn Erfelijk en Familiair Ovariumcarcinoom [Guideline Hereditary and Familial Ovarian Carcinoma]. Published June 1, 2015. Accessed October 6, 2017. https:\/\/www.nvog.nl\/wp-content\/uploads\/2018\/02\/Erfelijk-en-familiair-ovariumcarcinoom-1.0-28-05-2015.pdf"},{"key":"coi210020r17","unstructured":"National Cancer Institute. Common Terminology Criteria for Adverse Events (CTCAE) version 4.0. Published May 28, 2009. Accessed April 18, 2021. https:\/\/evs.nci.nih.gov\/ftp1\/CTCAE\/CTCAE_4.03\/Archive\/CTCAE_4.0_2009-05-29_QuickReference_8.5x11.pdf?"},{"key":"coi210020r27","unstructured":"Surgery in preventing ovarian cancer in patients with genetic mutations. ClinicalTrials.gov identifier: NCT02760849. Updated March 11, 2021. Accessed April 27, 2021. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02760849"},{"key":"coi210020r28","unstructured":"TUBectomy with delayed oophorectomy in high risk women to assess the safety of prevention (TUBA-WISP-II). ClinicalTrials.gov identifier: NCT04294927. Updated June 5, 2020. Accessed April 27, 2021. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04294927"}],"container-title":["JAMA Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaoncology\/articlepdf\/2780476\/jamaoncology_steenbeek_2021_oi_210020_1628879179.82688.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,19]],"date-time":"2021-08-19T18:28:10Z","timestamp":1629397690000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaoncology\/fullarticle\/2780476"}},"subtitle":["A Nonrandomized Controlled Trial"],"short-title":[],"issued":{"date-parts":[[2021,8,1]]},"references-count":28,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,8,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaoncol.2021.1590","relation":{},"ISSN":["2374-2437"],"issn-type":[{"value":"2374-2437","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8,1]]}}}